8.2.2 Flashcards

1
Q

What is self-report in measuring non-adherence?

A

It involves patients completing questionnaires about their adherence to treatment, such as the Medication Adherence Report Scale (MARS).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What format does the Medication Adherence Report Scale (MARS) use?

A

A forced-choice yes/no format.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List three advantages of using self-report to measure adherence.

A

It is cheap, quick, and can collect data from a large number of people, increasing generalizability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are two main disadvantages of self-report methods?

A

They rely on patient memory (reducing reliability) and are subject to social desirability bias (reducing validity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a semi-structured clinical interview in the context of non-adherence measurement?

A

A focused dialogue between the patient and practitioner designed to elicit details about adherence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the Medical Adherence Measure (MAM)?

A

A tool designed to obtain adherence details from patients through clinical interviews.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is the success of a semi-structured interview dependent on the patient-practitioner relationship?

A

Patients are more likely to be honest if they feel comfortable with the practitioner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are two strengths of semi-structured interviews in adherence research?

A

They provide detailed qualitative data, increasing validity and usefulness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List three disadvantages of semi-structured interviews.

A

They are time-consuming, expensive, and have a high drop-out rate, leading to lower generalizability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the aim of Riekert and Drotar’s (1999) study?

A

To assess the implications of non/incomplete participation of adolescents with diabetes in treatment adherence research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What was the sample size of the study?

A

Initially 94 families, but only 52 completed the study.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What method did the researchers use to assess adherence?

A

The Adherence and IDDM Questionnaire-R, interviews, and monitoring blood glucose levels using a reflectance meter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What were the main findings of Riekert and Drotar’s study?

A

Adolescents who did not return questionnaires had significantly lower adherence than those who completed them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What was the main conclusion of the study?

A

Lower adolescent adherence is associated with lower participation in adherence research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is pill counting used to measure adherence?

A

Patients bring their medication to the clinic, where the remaining pills are counted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can unannounced pill counts improve validity?

A

By conducting telephone or home visits, researchers can prevent patient manipulation of pill counts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What study supports the validity of pill counting?

A

Kalichman et al. (2008) found a 92% agreement between telephone/home pill counts and viral load measures in HIV+ patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are two disadvantages of pill counting?

A

It is burdensome for patients who must bring medication to appointments, and patients may manipulate the pill count if they know the date and time.

19
Q

What are medication dispensers

A

and how do they work?

20
Q

What is a major advantage of medication dispensers for patients?

A

They serve as reminders, reducing forgetfulness and preventing relapse.

21
Q

Why do medication dispensers lack validity in adherence measurement?

A

Just because a pill is removed does not mean it has been taken.

22
Q

What type of non-adherence do medication dispensers help reduce?

A

Unintentional non-adherence caused by forgetfulness.

23
Q

What was the aim of Chung and Naya (2000)?

A

To electronically assess compliance with an oral asthma medication.

24
Q

What technology did they use to track medication adherence?

A

TrackCap, which recorded the date and time the pill bottle was opened.

25
Q

What was the sample size and age range?

A

47 asthma patients aged 18–55.

26
Q

What were the compliance rates found using TrackCap and pill count?

A

80% compliance with TrackCap and 89% compliance with pill count.

27
Q

What was a key issue found in the study?

A

20% of participants under-complied by only removing one tablet daily instead of two.

28
Q

What was the main conclusion?

A

Monitoring systems like TrackCap effectively measure adherence but may not reflect actual medication intake.

29
Q

Why is urine analysis used to measure adherence?

A

It provides objective visual results of medication presence in the body.

30
Q

List two advantages of urine analysis.

A

It is cheap, non-invasive, and chemically stable for 14 days under refrigeration.

31
Q

What is a major disadvantage of urine analysis?

A

Drug/drug and drug/food interactions can interfere with accuracy.

32
Q

What are the two main methods of blood sampling for adherence testing?

A

Traditional blood sampling and dried blood spot (DBS) testing.

33
Q

What did Burnier (2020) find about DBS testing?

A

DBS can measure hypertension drugs as reliably as traditional plasma testing.

34
Q

Why is DBS testing preferred over traditional blood sampling?

A

It is less stressful and invasive for patients.

35
Q

What is a disadvantage of traditional blood sampling?

A

It is invasive and can be stressful for some patients.

36
Q

How does Riekert and Drotar’s study apply to real life?

A

It shows that families who do not complete research tasks may lack organizational skills, helping design adherence interventions.

37
Q

Why is the Chung and Naya study relevant to real-life adherence?

A

It measured adherence in home settings where patients normally take medication.

38
Q

What ethical issue is raised by Riekert and Drotar (1999)?

A

They used data from non-consenters, raising concerns about informed consent.

39
Q

What ethical issue is raised by Chung and Naya (2000)?

A

Patients were deceived about how their medication adherence was monitored.

40
Q

Why is electronic monitoring considered more valid than self-report?

A

It eliminates social desirability bias and memory errors.

41
Q

What was the main methodological strength of Riekert and Drotar’s study?

A

They used method triangulation, combining qualitative and quantitative data.

42
Q

Why was Chung and Naya’s study potentially lacking in validity?

A

Participants knew their adherence was being measured, which may have influenced behavior.

43
Q

How can research into non-adherence improve the medical profession?

A

It helps identify reasons for non-adherence and develop strategies to improve adherence.